Molecular Pathology Laboratory Network Inc., (MPLN), will celebrate 20 years of success in the healthcare and molecular diagnostics industry on July 1, 2009. Read the rest of this entry »
Download the PDF file by clicking the link below:
The U.S. Food and Drug Administration (FDA) recently approved Hologic, Inc.’s premarket approval application for the Cervista HPV 16/18 tests, which is performed at Molecular Pathology Laboratory Network, Inc. (MPLN). Cervista HPV 16/18 is the first HPV test cleared for genotyping for HPV types 16 and 18. Read the rest of this entry »
Clinical practice information about the CellSearch® Circulating Tumor Cell (CTC) Test for metastatic breast, colorectal and prostate cancers will be featured during a series of web conferences starting in March, 2009. Read the rest of this entry »
The latest information about the CellSearch® Circulating Tumor Cell (CTC) Test for metastatic prostate cancer will be featured in a series of web conferences starting in April, 2009. Read the rest of this entry »
The latest information about the CellSearch® Circulating Tumor Cell (CTC) Test for metastatic breast cancer will be featured in a series of web conferences starting in April, 2009. Read the rest of this entry »
Using the anti-EGFR therapy cetuximab (Erbitux) to treat patients with metastatic colorectal cancer who have the normal form of the KRAS gene would save more than $600 million annually, according to study results presented at the Gastrointestinal Cancers Symposium on January 14, 2009. For more information about the study, visit the National Cancer Institute online at www.cancer.gov.
The February 2009 issue of ASCP’s LabMedicine™ features an article about B-cell lymphoma with intermediate- to high- grade features and different immunophenotypic profiles involving separate anatomic sites with a good response to R-CHOP.
The article, which was written by Dr. Ron Lee and co-authored by several laboratory directors and medical technologists at Molecular Pathology Laboratory Network, Inc., presents a case study that highlights morphology, flow cytometry, fluorescence in situ hybridization (FISH), cytogenetics, and molecular testing in an interesting case of B-cell lymphoma.
To read the article, visit the ASCP publication online at www.labmedicine.com.
The January 2009 issue of the Journal of Molecular Diagnostics features a special article on laboratory guidelines for detecting and reporting BCR-ABL drug resistance mutations in chronic myelogenous leukemia and acute lymphoblastic. Read the rest of this entry »
Download the PDF file by clicking the link below: